Nasdaq-listed BioSig arranges $1.1B financing to tokenize commodities market after merger with Streamex

The Block

2025-07-08 18:13:13

に共有します

Nasdaq-listed medical technology firm BioSig Technologies (BSGM) has reached a definitive agreement with an undisclosed institutional investor for up to $1.1 billion in growth capital, which will fund the company's plan to tokenize the commodities market, according to a press release on Monday.

The new cash comes in two parts, including $100 million of senior secured convertible debentures and a $1 billion equity line of credit. BioSig will issue the debentures at 96 cents on the dollar. The notes mature in 24 months, with a 4% annual interest that jumps to 18% if the company defaults and is convertible into common stock. Additionally, the equity line enables BioSig to sell shares to the investor over a 36-month period.

Closing for the initial $75 million tranche of debentures and activation of the equity line is set for Oct. 7, 2025, subject to shareholder approval under Nasdaq rules and other customary conditions. A second $25 million tranche will be funded upon other regulatory-mandated closing requirements. Tether custodian Cantor Fitzgerald and Clear Street co-led BioSig’s placement. BSGM shares surged 10% at Monday's market close and over 22% in pre-open trading on Tuesday, Yahoo Finance data shows.

The financing arrived shortly after BioSig completed its merger with Bahamas-based Streamex Exchange Corporation, a deal that pivoted the medical device maker toward real-world asset tokenization.

Streamex specializes in bringing RWAs — especially commodities like gold — onchain to expand access and optimize investment rails. The company believes that gold tokenization could outpace Bitcoin’s performance, citing higher trading volume, greater market capitalization, and increased institutional adoption.

BioSig and Streamex intend to launch a gold-backed treasury management strategy with fresh funding. However, tokenization of the massive commodities market forms a larger part of the capital raise, BioSig CEO and Streamex Co-Founder Henry McPhie said. “Our mission is to unlock liquidity, transparency, and accessibility across the $142 trillion commodities market, and this milestone is just the beginning,” he stated.

The move comes amid a global drive toward tokenization, a market that Ripple projects will explode from around $12.8 billion per DefiLlama data on July 8 to over $18.9 trillion by 2033.

Disclaimer: The Block is an independent media outlet that delivers news, research, and data. As of November 2023, Foresight Ventures is a majority investor of The Block. Foresight Ventures invests in other companies in the crypto space. Crypto exchange Bitget is an anchor LP for Foresight Ventures. The Block continues to operate independently to deliver objective, impactful, and timely information about the crypto industry. Here are our current financial disclosures.